Relieve dyspepsia, reduce health service costs
- PPI can help mask tumours in dyspepsia. // Pulse;10/19/2011, Vol. 71 Issue 34, p14
The article offers tips on the use of proton pump inhibitor (PPI) in patient with dyspepsia.
- Economic Analysis of On-Demand Maintenance Therapy with Proton Pump Inhibitors in Patients with Non-Erosive Reflux Disease. Hughes, Dyfrig A.; Bodger, Keith; Bytzer, Peter; de Herdt, Dirk; Dubois, Dominique // PharmacoEconomics;2005, Vol. 23 Issue 10, p1031
Aim: To evaluate the costs and effectiveness of on-demand maintenance therapy with oral esomeprazole, lansoprazole, omeprazole, pantoprazole or rabeprazole in patients with endoscopy-confirmed non-erosive reflux disease (NERD) in the UK. Methods: A probabilistic model was developed to compare...
- PPIs and clopidogrel. // Critical Care Alert;May2009 Pharmacology Watch, p2
The article focuses on the efficiency of proton pump inhibitors (PPIs) in reducing the effect of clopidogrel on platelet aggregate.
- EXTENDED USE OF PPIs. HONK, CHERIE; Campbell, Eileen F. // Clinical Advisor;Aug2011, Vol. 14 Issue 8, p61
The article provides an answer to a question on the effects of taking proton pump inhibitors (PPIs) over an extended period of time.
- LATELINES. // Drug Topics;8/6/2001, Vol. 145 Issue 15, p5
Presents news briefs in the United States related to health and drugs, as of August 2001. Clearance received by a drug maker to market ribavirin capsules; Changes made on the packaging of Aciphex proton pump inhibitor; Details of a proposed legislation to use cigarette tax in funding SeniorCare...
- The Therapeutic and Diagnostic Value of 2-week High Dose Proton Pump Inhibitor Treatment in Overlapping Non-erosive Gastroesophageal Reflux Disease and Functional Dyspepsia Patients. Kriengkirakul, Chatchai; Patcharatrakul, Tanisa; Gonlachanvit, Sutep // Journal of Neurogastroenterology & Motility;2012, Vol. 18 Issue 2, p174
Background/Aims To evaluate the value of a 2-week high dose proton pump inhibitor (PPI) treatment on patients with overlapping non-erosive gastroesophageal reflux disease (NERD) and functional dyspepsia (FD). Methods Sixty overlapping NERD and FD patients with symptom onset > 3 months prior...
- Comparative Drug Effects: The Case of GERD Therapies. Wertheimer, Albert I.; Wilson, James M. // Disease Management;Feb2007, Vol. 10 Issue 1, p46
The results of clinical trials and approved Food and Drug Administration Drug Applications inform decision makers that a drug was effective in its labeled indications without causing unacceptable side effects. But purchasers for large medical organizations and members of health insurer or...
- Managing gastroesophageal reflux disease - comparative efficacy and outcomes of dexlansoprazole MR. Frye, Jeanetta W.; Peura, David A. // Therapeutics & Clinical Risk Management;2015, Vol. 11, p1649
The management of gastroesophageal reflux disease (GERD) has been revolutionized with the development of proton pump inhibitors (PPIs). Unfortunately, due to the inherent pharmacokinetic and pharmacodynamic profiles of conventional PPIs, many patients continue to suffer from symptoms related to...
- Proton pump inhibitors - over-prescribed in a rural community? Shafi, Sadaf; Soomro, Rehmatullah; Abbas, Syed Zafar // Pakistan Journal of Medical Sciences;Mar2011, Vol. 27 Issue 2, p300
Objectives: There are specific licensed indications for the use of Proton Pump Inhibitors (PPIs). However it is over-prescribed globally. We performed a study to find out the uses and misuses of this expensive drug in our rural and financially poor population. Methodology: Prospective survey of...